Circular Genomics
Circular Genomics provides RNA-based diagnostics and therapeutics for treating depression and other psychiatric and neurological conditions. The company has developed circular RNA-based genomic assays that serve as biomarkers to predict therapeutic response for individuals with psychiatric disorders, enabling personalized treatment selection. Founded in 2021 and headquartered in Albuquerque, United States, Circular…
Funding snapshot
About
Circular Genomics provides RNA-based diagnostics and therapeutics for treating depression and other psychiatric and neurological conditions. The company has developed circular RNA-based genomic assays that serve as biomarkers to predict therapeutic response for individuals with psychiatric disorders, enabling personalized treatment selection. Founded in 2021 and headquartered in Albuquerque, United States, Circular Genomics has raised approximately $29M in Series A funding from investors including Mountain Group Partners, The University of New Mexico, Cottonwood Technology Fund, Tramway Venture Partners, and Alzheimer's Drug Discovery Foundation. The company employs 19 people and leverages circular RNA biomarkers, which are more stable than linear RNA, to develop diagnostic tests that can predict patient response to antidepressant medications, addressing the trial-and-error approach that currently characterizes psychiatric drug selection.
Business model
Neurology > In-Vitro Diagnostics > Diversified,
Genomics > Applied Genomics > Clinical Genomics > Theranostics
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.